Cardiovascular biomarker midregional proatrial natriuretic peptide during and after preeclamptic pregnancies

Hypertension

Volumn 59, Issue 2 SUPPL. 1, 2012, Pages 395-401

  Sugulle, Meryam ^a,b   Herse, Florian ^c   Hering, Lydia ^c   Mockel, Martin ^d   Dechend, Ralf ^c,e   Staff, Anne Cathrine ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HELIOS Clinic   (Germany)

Author keywords

biological marker; cardiovascular disease; midregional proatrial natriuretic peptide; postpartum; preeclampsia; pregnancy; transgenic rats

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; MIDREGIONAL PROATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; MESSENGER RNA; MIDREGIONAL PRO ATRIAL NATRIURETIC PEPTIDE, HUMAN; MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE, HUMAN; ANTIHYPERTENSIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FETUS HEART; GESTATION PERIOD; HEART; HUMAN; IMMUNOASSAY; KIDNEY; MAJOR CLINICAL STUDY; MATERNAL PLASMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC RAT; ANIMAL; ARTICLE; DISEASE MODEL; HEART MUSCLE; METABOLISM; PREGNANCY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ANTIHYPERTENSIVE THERAPY; DECIDUA; HYPERTENSION; PREGNANT WOMAN; QUANTITATIVE ASSAY;

ADULT; ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KIDNEY; MYOCARDIUM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RATS; RATS, TRANSGENIC; RISK FACTORS; RNA, MESSENGER;

EID: 84856082157     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.185264     Document Type: Conference Paper

References (40)

1. American College of Obstetricians and Gynecologists. ACOG practice bulletin: Diagnosis and management of preeclampsia and eclampsia- number 33, January 2002. Int J Gynaecol Obstet. 2002;77:67-75.
2. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63:534-543.
3. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594. (Pubitemid 40807500)
4. Roberts JM, Redman CWG. Preeclampsia: More than pregnancy-induced hypertension. Lancet. 1993;341:1447-1451. (Pubitemid 23161452)
5. Harskamp RE, Zeeman GG. Preeclampsia: At risk for remote cardiovascular disease. Am J Med Sci. 2007;334:291-295. (Pubitemid 351339288)
6. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small lowdensity lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 1998; 47:1281-1288. (Pubitemid 28469258)
7. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. BMJ. 2001;323:1213-1217.
8. Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112:1486-1491. (Pubitemid 43961234)
9. Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man. Clin Sci (Lond). 1986;71:151-155. (Pubitemid 16059793)
10. Rodeheffer RJ, Tanaka I, Imada T, Hollister AS, Robertson D, Inagami T. Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol. 1986;8:18-26. (Pubitemid 16094108)
11. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350:655-663. (Pubitemid 38364624)
12. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di SS, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von HS, Bergmann A, Morgenthaler NG, Anker SD. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: Results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010;55:2062-2076.
13. Hatjis CG, Greelish JP, Kofinas AD, Stroud A, Hashimoto K, Rose JC. Atrial natriuretic factor maternal and fetal concentrations in severe preeclampsia. Am J Obstet Gynecol. 1989;161:1015-1019. (Pubitemid 19266224)
14. Thomsen JK, Storm TL, Thamsborg G, de NM, Bodker B, Skouby S. Atrial natriuretic peptide concentrations in pre-eclampsia. BMJ (Clin Res Ed). 1987;294:1508-1510. (Pubitemid 17108385)
15. Zunker P, Happe S, Louwen F, Evers S, Ringelstein EB. Peripartal temporal course of endothelin 1, angiotensin II, and atrial natriuretic peptide in pre-eclampsia and normotensive pregnancy. Fetal Diagn Ther. 1998;13:309-314. (Pubitemid 28522150)
16. Borghi C, Esposti DD, Immordino V, Cassani A, Boschi S, Bovicelli L, Ambrosioni E. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol. 2000;183:140-147. (Pubitemid 30626041)
17. Nisell H, Carlstrom K, Cizinsky S, Grunewald C, Nylund L, Randmaa I. Atrial natriuretic peptide concentrations and hemodynamic effects of acute plasma volume expansion in normal pregnancy and preeclampsia. Obstet Gynecol. 1992;79:902-907.
18. Rizk DE. A study ofβ-human atrial natriuretic peptide in normal pregnancy and in pre-eclampsia. J Obstet Gynaecol. 1997;17:234-238. (Pubitemid 27281556)
19. Pouta AM, Hartikainen AL, Vuolteenaho OJ, Ruokonen AO, Laatikainen TJ. Midtrimester N-terminal proatrial natriuretic peptide, free αhCG, andβ-fetoprotein in predicting preeclampsia. Obstet Gynecol. 1998;91: 940-944. (Pubitemid 28246927)
20. Morgenthaler NG, Struck J, Thomas B, Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem. 2004;50:234-236. (Pubitemid 38125732)
21. Ala-Kopsala M, Magga J, Peuhkurinen K, Leipala J, Ruskoaho H, Leppaluoto J, Vuolteenaho O. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem. 2004;50:1576-1588. (Pubitemid 39121226)
22. Johnsen SL, Rasmussen S, Wilsgaard T, Sollien R, Kiserud T. Longitudinal reference ranges for estimated fetal weight. Acta Obstet Gynecol Scand. 2006;85:286-297. (Pubitemid 43879213)
23. Arduini D, Rizzo G. Normal values of pulsatility index from fetal vessels: A cross-sectional study on 1556 healthy fetuses. J Perinat Med. 1990;18: 165-172. (Pubitemid 20217555)
24. Kvehaugen AS, Andersen LF, Staff AC. Anthropometry and cardiovascular risk factors in women and offspring after pregnancies complicated by preeclampsia or diabetes mellitus. Acta Obstet Gynecol Scand. 2010; 89:1478-1485.
25. Braekke K, Holthe MR, Harsem NK, Fagerhol MK, Staff AC. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol. 2005;193: 227-233. (Pubitemid 40991850)
26. Dechend R, Gratze P, Wallukat G, Shagdarsuren E, Plehm R, Brasen JH, Fiebeler A, Schneider W, Caluwaerts S, Vercruysse L, Pijnenborg R, Luft FC, Muller DN. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension. 2005;45:742-746. (Pubitemid 40418375)
27. Hering L, Herse F, Geusens N, Verlohren S, Wenzel K, Staff AC, Brosnihan KB, Huppertz B, Luft FC, Muller DN, Pijnenborg R, Cartwright JE, Dechend R. Effects of circulating and local uteroplacental angiotensin II in rat pregnancy. Hypertension. 2010;56:311-318.
28. Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Muller B, Christ-Crain M. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol. 2010;56:1045-1053.
29. Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: Comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem. 2006;52: 827-831. (Pubitemid 43673260)
30. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683. (Pubitemid 38364626)
31. Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Am J Obstet Gynecol. 1985;151: 958-966. (Pubitemid 15237734)
32. Melchiorre K, Sutherland GR, Baltabaeva A, Liberati M, Thilaganathan B. Maternal cardiac dysfunction and remodeling in women with preeclampsia at term. Hypertension. 2011;57:85-93.
33. Benedetti TJ, Kates R, Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol. 1985;152:330-334. (Pubitemid 15049762)
34. Khaleghi M, Saleem U, Morgenthaler NG, Turner ST, Bergmann A, Struck J, Mosley TH, Kullo IJ. Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. Am J Hypertens. 2009;22:425-431.
35. Woodard GE, Rosado JA. Natriuretic peptides in vascular physiology and pathology. Int Rev Cell Mol Biol. 2008;268:59-93.
36. Sumioki H, Shimokawa H, Miyamoto S, Uezono K, Utsunomiya T, Nakano H. Circadian variations of plasma atrial natriuretic peptide in four types of hypertensive disorder during pregnancy. Br J Obstet Gynaecol. 1989;96:922-927. (Pubitemid 19209981)
37. Tihtonen KM, Koobi T, Vuolteenaho O, Huhtala HS, Uotila JT. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol. 2007;196:328-327.
38. Malee MP, Malee KM, Azuma SD, Taylor RN, Roberts JM. Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab. 1992;74:1095-1100.
39. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58:709-715.
40. Cindrova-Davies T, Yung HW, Johns J, Spasic-Boskovic O, Korolchuk S, Jauniaux E, Burton GJ, Charnock-Jones DS. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol. 2007;171:1168-1179. (Pubitemid 47582891)